Business● Low1h ago · Nov 4, 2026, 7:16 AM
AtriCure projects 2026 adjusted EBITDA of $91M-$94M as it targets BoxX-NoAF enrollment completion by year-end
GlobeAlert Desk · curated from Seeking Alpha Tech · global
AtriCure projects an adjusted EBITDA of $91M-$94M for 2026 and aims to complete enrollment for its BoxX-NoAF program by year-end. This provides insight into the company's financial outlook and strategic goals.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business35m agoNaidu writes to Piyush Goyal on 150 chilli containers held at Colombo port over moisture contentThe HinduBusiness38m agoTORM GAAP EPS of $1.91, revenue of $499M beats by $143.39M; raises FY2026 outlookSeeking Alpha TechBusiness46m agoAI stocks tied to Texas data center boom slide after Hinojosa winSeeking Alpha TechBusiness49m agoBayerische Motoren Werke Aktiengesellschaft GAAP EPS of €2.46, revenue of €30.45BSeeking Alpha Tech